biophonics.co.uk valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:
Meta Tags
Title Biophonics
Description Early screening of your heart Home The Problem Our Solution Team News Contact Us Select Page Early screening of your heart valves We are combining world-leading AI and acoustics in a m
Keywords N/A
Server Information
WebSite biophonics faviconbiophonics.co.uk
Host IP 54.76.63.168
Location Ireland
Related Websites
Site Rank
More to Explore
biophonics.co.uk Valuation
US$1,194
Last updated: 2023-05-19 16:57:46

biophonics.co.uk has Semrush global rank of 0. biophonics.co.uk has an estimated worth of US$ 1,194, based on its estimated Ads revenue. biophonics.co.uk receives approximately 137 unique visitors each day. Its web server is located in Ireland, with IP address 54.76.63.168. According to SiteAdvisor, biophonics.co.uk is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,194
Daily Ads Revenue US$1
Monthly Ads Revenue US$33
Yearly Ads Revenue US$396
Daily Unique Visitors 9
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
biophonics.co.uk. A 599 IP: 54.76.63.168
biophonics.co.uk. NS 3600 NS Record: ns60.domaincontrol.com.
biophonics.co.uk. NS 3600 NS Record: ns59.domaincontrol.com.
biophonics.co.uk. MX 3600 MX Record: 5 alt2.aspmx.l.google.com.
biophonics.co.uk. MX 3600 MX Record: 1 aspmx.l.google.com.
biophonics.co.uk. MX 3600 MX Record: 10 aspmx2.googlemail.com.
biophonics.co.uk. MX 3600 MX Record: 10 aspmx3.googlemail.com.
biophonics.co.uk. MX 3600 MX Record: 5 alt1.aspmx.l.google.com.
biophonics.co.uk. TXT 3600 TXT Record: v=spf1 include:_spf.google.com ~all
biophonics.co.uk. TXT 3600 TXT Record: google-site-verification=UDTSfYF3up9tdQyTzUVo1WeFHN924tZrk8p1Yrh2h3k
HtmlToTextCheckTime:2023-05-19 16:57:46
Home The Problem Our Solution Team News Contact Us Select Page Early screening of your heart valves We are combining world-leading AI and acoustics in a medical device that enables widespread early screening of valvular heart disease, preventing costly late detection of heart failure. 1 in 9 over 65s have significant valvular heart disease. This is nearly 2 million people in the UK and will grow rapidly due to the ageing population. 50% of patients are undiagnosed and will progress to late stage where the prognosis is worse than advanced stage cancer. £345m additional cost to the NHS per year because of treating patients at a later, symptomatic stage. The current detection pathway for VHD is inadequate 1. Symptoms Patients mistake the classic symptoms of valvular heart disease (breathlessness, fatigue) for other conditions or just the natural process of ageing. As a result, they wait until a late stage before contacting the healthcare system. 2. GP stethoscope exam Patients with VHD
HTTP Headers
HTTP/1.1 302 Found
Date: Sun, 30 Oct 2022 08:49:37 GMT
Server: Apache
X-Frame-Options: SAMEORIGIN
Location: https://biophonics.co.uk/
Content-Type: text/html; charset=iso-8859-1

HTTP/1.1 200 OK
Date: Sun, 30 Oct 2022 08:49:37 GMT
Server: Apache
X-Powered-By: PHP/7.0.27
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
X-Frame-Options: SAMEORIGIN
Cache-Control: max-age=0, no-cache
Content-Type: text/html; charset=UTF-8